New Articles

  1. Reflecting on Informed Financial Consent in Clinical Practice - Post Webinar Activity

    Created On: 23/04/2026 in CPD Education
    This CPD activity is divided into two sections. We expect that completing both sections should take you 1.5 hours. Section A  – Educational Activity - 0.5 hours Section B  – Reviewing Performance - 1 hour Online Form - ...

  2. Beyond clinical consent: Understanding your obligations under the new legislative landscape

    Created On: 15/04/2026
    Following recent reforms to the Health Insurance Act 1973 and related provisions under the Private Health Insurance (Health Insurance Business) Rules 2025, Australian healthcare practitioners now face enhanced legal obligations in obtaining and ...

  3. ADHD prescribing: Reviewing Performance and Measuring Outcomes in clinical practice Post Webinar Activity

    Created On: 09/04/2026 in CPD Education
    Time to complete: 4 hours This CPD activity is divided in two sections. We expect that completing both sections should take you 4 hours.  Section A – (Reviewing Performance - 1 hour) Section B – (Measuring Outcomes - 3 hour...

  4. Quality and accountability in informed financial consent: Reviewing Performance in clinical practice - pre webinar activity

    Created On: 05/04/2026
    1 hour Reviewing Performance (RP) This Reviewing Performance Activity invites you to reflect on hypothetical case scenarios that highlight potential areas of medicolegal risk when obtaining informed financial consent. Online Fo...

  5. Managing Medico-Legal Risks in ADHD Prescribing

    Created On: 01/04/2026 in CPD Education Webinars
    In this webinar, our expert panel will explore the key medicolegal risks in prescribing ADHD medications, including documentation and compliance with controlled substances guidelines. They’ll also discuss emerging challenges linked to evolving...

  6. Weight loss prescribing: know the risks before you prescribe

    Created On: 30/03/2026 in Medico-Legal News Ahpra Regulations
    Prescribing weight loss medications has never attracted more attention – or more regulatory scrutiny. With GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) now widely sought by patients, MIPS has see...

  7. What the Kitchen v Quinlivan decision means for practitioners with PSR history

    Created On: 30/03/2026 in Medico-Legal News Legal & Regulatory
    A landmark Queensland Supreme Court decision has put the Professional Services Review (PSR) process under the spotlight, and if you have been through a PSR investigation, you may be wondering whether it has any bearing on your situation. In Kitc...

  8. Is someone using your name online? What every practitioner should know

    Created On: 30/03/2026 in Medico-Legal News Privacy & Confidentiality
    Imagine searching your own name online and finding your photo on a website promoting a supplement you've never heard of, or a health service you've never been associated with. Your credentials are listed and your professional headshot is right the...

  9. Managing Medico-Legal Risks in ADHD Prescribing - Pre-webinar activity

    Created On: 12/03/2026
    This CPD activity is 1.0 hour of CPD under the Reviewing Performance (1.0 hour) category Online Form - Reviewing Performance of medicolegal risks in ADHD prescribing - Pre webinar activity ...

  10. Privacy update: assessing performance and evaluating outcomes in clinical practice - Post Webinar Activity

    Created On: 05/03/2026
    Time to complete: 5 hours This CPD activity is divided in two sections. We expect that completing both sections should take you 4 hours.  Section A  – (Reviewing Performance - 1 hour) invites you to undertake a Root-Cause-Analysis (...
Back to top